Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sangamo Therapeutics (SGMOQ) Return on Sales [ROS] (2010 - 2025)

Updated

Sangamo Therapeutics (SGMOQ) posted Return on Sales [ROS] of -268.51% for Q4 2025, up 75.69 percentage points from -344.19% a year earlier and up 5850.77 percentage points from the prior quarter.

Analysis

Sangamo Therapeutics (SGMOQ) Return on Sales [ROS] (2010 - 2025) Analysis & Trends

For FY2025, Sangamo Therapeutics' Return on Sales [ROS] came in at -306.53%, down 126.65 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of -196.92 percentage points (FY2020 to FY2025).
  • In prior years, Sangamo Therapeutics' Return on Sales [ROS] was -179.88% in FY2024 (-24.40 pp), -155.48% in FY2023 (+25.37 pp), -180.85% in FY2022 (-15.23 pp) and -165.61% in FY2021 (-56.00 pp).
  • Quarterly Return on Sales [ROS] has run from a low of -10712.27% in Q1 2024 to a high of 21.52% in Q3 2024 over five years.
  • On a year-over-year basis, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of -122.21 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2025, with a gain of 10319.32 percentage points; the weakest was Q1 2024, with a drop of 10723.68 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -6119.28% (Q3 2025), -97.54% (Q2 2025) and -460.28% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Sangamo Therapeutics 42.03 Mn -72.08 Mn - -268.51%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -268.51%
Sep 30, 2025 -6,119.28%
Jun 30, 2025 -97.54%
Mar 31, 2025 -460.28%
Dec 31, 2024 -344.19%
Sep 30, 2024 21.52%
Jun 30, 2024 -10,416.85%
Mar 31, 2024 -10,712.27%
Dec 31, 2023 -3,039.13%
Sep 30, 2023 -1,132.24%
Jun 30, 2023 -1,807.93%
Mar 31, 2023 11.42%
Dec 31, 2022 -203.42%
Sep 30, 2022 -207.46%
Jun 30, 2022 -155.67%
Mar 31, 2022 -160.32%
Dec 31, 2021 -142.57%
Sep 30, 2021 -169.58%
Jun 30, 2021 -174.73%
Mar 31, 2021 -176.19%
API Access

Sangamo Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY